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OBJECTIVE — The purpose of this study was to determine whether implementation of a
multicomponentorganizationalinterventioncanproducesigniﬁcantchangeindiabetescareand
outcomes in community primary care practices.
RESEARCH DESIGN AND METHODS — This was a group-randomized, controlled
clinicaltrialevaluatingthepracticaleffectivenessofamulticomponentintervention(TRANSLATE)in
24 practices. The intervention included implementation of an electronic diabetes registry, visit re-
minders, and patient-speciﬁc physician alerts. A site coordinator facilitated previsit planning and a
monthly review of performance with a local physician champion. The principle outcomes were the
percentageofpatientsachievingtargetvaluesforthecompositeofsystolicbloodpressure(SBP)130
mmHg, LDL cholesterol 100 mg/dl, and A1C 7.0% at baseline and 12 months. Six process
measures were also followed.
RESULTS — Over 24 months, 69,965 visits from 8,405 adult patients with type 2 diabetes
were recorded from 238 health care providers in 24 practices from 17 health systems. Diabetes
process measures increased signiﬁcantly more in intervention than in control practices, giving
netincreasesasfollows:footexaminations35.0%(P0.0.001);annualeyeexaminations25.9%
(P  0.001); renal testing 28.5% (P  0.001); A1C testing 8.1%(P  0.001); blood pressure
monitoring3.5%(P0.05);andLDLtesting8.6%(P0.001).MeanA1Cadjustedforage,sex,
and comorbidity decreased signiﬁcantly in intervention practices (P  0.02). At 12 months,
interventionpracticeshadsigniﬁcantlygreaterimprovementinachievingrecommendedclinical
values for SBP, A1C, and LDL than control clinics (P  0.002).
CONCLUSIONS — Introduction of a multicomponent organizational intervention in the
primary care setting signiﬁcantly increases the percentage of type 2 diabetic patients achieving
recommended clinical outcomes.
Diabetes Care 31:2238–2243, 2008
A
lthough the achievement of evi-
dence-based clinical goals signiﬁ-
cantly reduces the risk of morbidity
and mortality in type 2 diabetes, the de-
livery of care in community practices and
referral centers often falls short of these
goals (1–4). Although the need to im-
prove diabetes services in the U.S. is well
documented, few clinical interventions
have been shown to effectively improve
patient outcomes in diverse primary care
settings(5).Because80%ofadultswith
diabetes receive their care from primary
care physicians, the community primary
care practice is a logical focal point for
implementing strategies that improve
care delivery. Practical intervention strat-
egies are needed to ensure that the latest
and most effective scientiﬁc recommen-
dationsfordiabetescarearerapidlytrans-
lated to the community (6,7).
Problems with the organization and
delivery of health care services contribute
to the nation’s inability to reach current
evidence-based goals for optimal chronic
disease control (8,9). Among large medi-
cal groups, fewer than half have imple-
mented improvement tools such as
diabetes registries, tracking systems, case
managers,feedbacktophysicians,orclin-
ical guidelines with reminders, whereas
other systems lack the technology neces-
sary to sustain quality improvement ef-
forts (5,10–12). Many diabetes
intervention studies are limited by inade-
quate sample size, nonrandomized pa-
tientsandclinics,lackofcontrolsubjects,
or limited scope of implementation
within a single medical group or health
system (11,13,14). Although some trials
of quality improvement strategies have
demonstrated small improvements in the
process of care delivery, demonstrating
improvementincontrolofA1C,LDL,and
systolic blood pressure (SBP) has been
morechallenging(15–18).Thepaucityof
effective interventions improving diabe-
tes care in primary care settings led us to
design a “practical clinical trial” to test
whether implementation of an organiza-
tional intervention could improve both
diabetes care processes and clinical out-
comes in primary care (19).
RESEARCH DESIGN AND
METHODS— TRANSLATE was a
group-randomized, controlled clinical
trialconductedin24communityprimary
carepractices.Thepracticewastheunitof
assignment, and each was randomly allo-
cated to either intervention or control
(20,21).Theinterventionwasdesignedas
apracticaltoolfromtheperspectiveofthe
health care system and was implemented
at the organizational level of the practice.
Practice selection and setting
PracticeswererecruitedthroughtheMin-
nesota Academy of Family Physicians Re-
search Network, a primary care practice–
based research network, and mail
solicitation using addresses from the state
medical society. Practices were eligible if
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specialtycommunityprimarycare(family
medicine or general internal medicine) to
reduce variation in the clinic population,
2)availabilityof24monthsofbillingdata,
3) 3–22 full-time equivalent providers, 4)
access to a computer with Internet capa-
bilitytofacilitatetheelectronicregistry,5)
willingness to join a regional quality im-
provement organization to provide data
abstraction support, and 6) location
within 200 miles to limit travel costs.
Practices that targeted racial or ethnic mi-
norities were preferred because they in-
creased diversity in the cohort. Practices
were excluded for the following: 1) exist-
ing electronic medical records, 2)a ne x -
isting electronic diabetes registry, or 3)
participationinadiabetes-speciﬁcquality
improvement program within the past
2 years.
Approximately104primarycareclin-
ics were contacted, of which 36 volun-
teered. After a telephone screen, 30
practices met the eligibility criteria. The
24 practices with the greatest racial and
ethnic diversity and staff interest in the
study were selected.
Population
Each practice submitted billing records
for all patients seen in the previous 24
months with one or more ICD-9-CM
codes for diabetes (250.xx, 357.2,
362.0x, 366.41, or 648.0). All patients
with type 1 or indeterminate classiﬁca-
tions were adjudicated by an endocrinol-
ogist blinded to practice identiﬁcation to
reduce classiﬁcation error. All type 2 dia-
betic patients aged 18–89 years on the
clinic start date were included in the
study cohort. Patients were excluded if
they were1) documented as not receiving
diabetes care at the practice (referred
care), 2) deceased, 3) no longer in the
practice (documented transfer or no con-
tact for 24 months), or 4) permanently
residing in a long-term care facility. Indi-
vidualsreceivingsomediabetescareatthe
practice (comanaged) were included.
Randomization
Practices were randomized in blocks of
four using six sets of opaque envelopes to
ensure that equal numbers of control and
intervention clinics were abstracted si-
multaneously. Envelopes were prepared
bythestatistician,assignedinorderofpost-
mark, and opened under observation.
Data collection
Medical records from all eligible patients
were abstracted by trained reviewers con-
currently in control and intervention
practices from June 2003 to June 2004.
Ten percent of records were randomly se-
lected and reabstracted. Differences were
reviewed to ensure uniform interpreta-
tion of the record and corrected. Abstrac-
tion averaged 3 weeks per clinic but
varied because of chart organization, leg-
ibility, and medical records stafﬁng.
Study measures were abstracted in an
identical fashion from all clinics exactly
12 months later.
Intervention
Theinterventionaffectedseveraldomains
in the Chronic Care Model (22). Speciﬁ-
cally, practice redesign was supported by
a clinical information system providing
patient-speciﬁc clinical decision support
and promoting proactive engagement of
patients. Speciﬁc components were di-
rected to the patient, the physician, and
the clinic staff (9).
In intervention practices, senior ad-
ministration personnel identiﬁed a site
coordinator and local physician cham-
pion (LPC). A small sticker was afﬁxed to
medical records of patients with diabetes
to assist identiﬁcation. An electronic dia-
betes registry was placed on a new or ex-
isting computer, and the site coordinator
was trained in its use. Although labora-
tory values were initially updated manu-
ally, electronic interfaces were rapidly
introduced. The site coordinator facili-
tated previsit planning and printed pa-
tient-speciﬁc physician reminders before
every visit by a diabetes patient. Remind-
ers for unscheduled appointments were
printed by the medical assistant when the
patient was roomed. Reminders graphed
A1C, SBP, and LDL values versus time
and indicated whether the patient had
achieved targets. An “alert” identiﬁed all
incomplete or overdue tests. Foot exami-
nations, blood pressure, and eye exami-
nationswererecordedonthereminderby
clinicstaff,collectedafterthepatientvisit,
and entered manually. The site coordina-
tor notiﬁed patients of scheduled visits
and contacted high-risk patients with el-
evated A1C or SBP. The site coordinator
used the registry to provide a monthly
summary describing operational activity
and tracking clinical measures. Reports
were reviewed monthly at a 1-hour staff
meetingchairedbytheLPC.TheLPCalso
coordinated two diabetes educational up-
dates for staff. Essential elements of the
intervention are summarized in Table 1.
Control practices were provided with
a report of their process and outcome
measures at baseline and were encour-
aged to continue usual quality improve-
ment. All practices were instructed to
target the same values.
Principal outcomes
The study evaluated the percentage of el-
igible patients achieving recommended
values for SBP, A1C, and LDL. For targets
to be achieved, the last recorded value
had to be current and controlled on the
designated abstraction date with SBP
130mmHg,A1C7.0%,andLDLcho-
lesterol100mg/dl.Sixdiabetes-speciﬁc
processes were measured for the 12-
month period before the start date (base-
line) and again 12 months later for the
intervention period using National Com-
mittee on Quality Assurance criteria (23).
Staffs at all practices were instructed
in American Heart Association blood
Table 1—Essential components of the intervention
Intervention
component Description
Target high risk Identify and begin with patients at highest risk.
Registry Create a registry for data collection, reporting, and support.
Administration Set up administration to oversees changes in roles and
responsibilities and enhance continuity during staff turnover.
Notify and remind Notify patients of targets and appointments. Remind providers at
time of visit with patient-speciﬁc alerts.
Site coordinator Identify a site coordinator to facilitate the clinic operations.
Local physician
champion
Identify a lead provider to work with the site coordinator and
facilitate the intervention with colleagues.
Audit and feedback Audit and review monthly. Provide feedback to improve progress.
Track Track process measures, outcomes, and operational activity.
Education Educate and update all staff in diabetes management techniques.
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duce granularity of SBP. All A1C mea-
sures were determined by National
Glycohemoglobulin Standardization Pro-
gram standardized laboratories. Mi-
croalbumin measures included timed
microalbumin, the microalbumin-to-
creatinine ratio, or dipstick microalbu-
min. Foot examinations and eye
examinations were recorded as present
onlyifbothexaminationandﬁndingwere
documented. LDL was measured using
the calculations of Freidewald on fasting
blood samples with triglycerides 400
mg/dl.
Analysis
Mixed models were used to account for
clustering of patients nested within pro-
viders and within practices, and correla-
tion of outcomes was replicated within
patients over time using SAS statistical
software(version9.1;SASInstitute,Cary,
NC) (24). For continuous outcomes we
used the general linear mixed model pro-
cedure(procMIXED).Forcategoricaland
count outcomes we used the generalized
linear mixed model (GLMM) as imple-
mentedintherecentlyreleasedGLIMMIX
procedure (25). This SAS procedure ac-
commodatescorrelatedoutcomesdistrib-
uted as a member of the natural
exponential family, which includes the
binomial and Poisson distributions as
well as the normal distribution.
Initial unadjusted GLMMs were used
for the quality of care measures and the
secondary outcomes with use of the bino-
mial link function. All remaining models
were adjusted for patient variation, in-
cluding age, sex, and the Charlson Co-
morbidityIndex(CCI).TheCCIwasused
to measure coexistent diseases and reﬂect
the severity of diabetes seen in the clinic
(26,27). For the composite outcomes
count measure we used GLMM with the
Poisson distribution.
Making allowances for missing data,
patient attrition, patient mortality, and
clinic withdrawal from the study, we de-
terminedthat24clinicswith250patients
each would provide a detectable differ-
ence in the composite measure (type I er-
ror0.05andtypeIIerror0.80)using
the general rule /SEM()  tdf, 1/2 
tdf, power. With d.f.  22, td.f., 1/2 
2.07, and td.f., power  0.86 and using
SEM()  0.030, then 0.030 
2.93  0.088. The SDs of the composite
measureinthepopulationcalculatedwith
baselinedatawereusedtointerpret0.088
of the detectable difference with an esti-
mated intraclass correlation of about 0.3.
The study, therefore, had 80% power to
detect a net difference of 0.088 in the
composite score.
Human subject protection
The East Metro Diabetes Initiative, a re-
gional quality-improvement organiza-
tion, installed registry software at all
clinics,assistedwithdataabstraction,and
de-identiﬁedalldatareleasedtoresearch-
ers. The study protocol was reviewed, ap-
proved in advance, and monitored by the
University of Minnesota Institutional Re-
view Board.
RESULTS— Of 13,531 patients iden-
tiﬁed as having type 2 diabetes from bill-
ing codes, 343 were adjudicated not to
have type 2 diabetes. An additional 4,783
did not meet the eligibility criteria. From
8,405 eligible patients, 1,304 died, trans-
ferred care to another practice, or were
admittedpermanentlytoalong-termcare
facility during the study period and were
excluded from analysis (688 control and
618 intervention). The eligible cohort
therefore included 7,101 patients (3,131
control and 3,970 intervention).
During the 12-month intervention,
214 cohort patients made no visit to their
practice (average 2.9% per clinic, range
0–7%). After the intervention period, all
practiceswereaskedtodeterminethesta-
tusofthesepatientsandhavethemreturn
for an A1C evaluation. From this group,
151 (71%) returned for evaluation (101
control and 50 intervention). Their aver-
age A1C values were not signiﬁcantly dif-
ferent: 7.16% and 7.63% for control and
intervention practices, respectively.
Eligible patients made 69,965 pro-
vider visits over 24 months. The 24 en-
rolled clinics included 238 providers
actively managing or comanaging an av-
erage of 62 type 2 patients per full-time
equivalent (FTE) provider (note that this
number excludes referred patients). On
average, each practice actively managed
296 (range 113–595) type 2 diabetic pa-
tients. The median size of the practices
was 5.9 (range 2–14) FTE providers.
Table2summarizesbaselinecharacter-
istics. No statistically signiﬁcant differences
existed between intervention and control
practices in patient demographics, total
number of diabetes complications, or rele-
vant clinical measures.
Table 3 summarizes process mea-
sures from baseline and intervention pe-
riods, the change, and the net difference
between groups. At 12 months, interven-
tion practices had made signiﬁcantly
greater net improvement in all process
measures than control practices.
Both intervention and control prac-
tices showed statistically signiﬁcant de-
clines in mean SBP for the total diabetes
populationadjustedforage,sex,andCCI,
dropping 1.50 	 0.368 mmHg (P 
0.002) in control practices and 1.26 	
0.321 mmHg (P  0.002) in intervention
Table 2—Baseline characteristics of type 2 diabetic patients
Control
clinics
Intervention
clinics P value
n 3,131 3,970
Age (years) 63.2 	 0.92 62.4 	 0.91 0.540
Female sex (%) 50.5 49.0 0.531
No. of physician visits 4.85 	 0.28 4.41 	 0.28 0.285
No. of diabetes complications 0.23 	 0.03 0.26 	 0.02 0.463
Nephropathy (%) 6.1 5.4 0.665
Neuropathy (%) 11.4 11.9 0.765
Retinopathy (%) 5.8 8.9 0.020*
Myocardial infarction (%) 16.1 18.9 0.189
Congestive heart failure (%) 4.2 3.4 0.352
Peripheral vascular disease (%) 4.3 4.3 0.986
Cerebrovascular disease (%) 5.3 6.5 0.106
Average A1C (%) 7.33 7.25 0.411
Average SBP (mmHg) 133.2 132.3 0.448
Average LDL (mg/dl) 103.6 104.1 0.709
Hypertension (SBP  130 mmHg) (%) 68.6 70.4 0.526
Hyperlipidemia (LDL  100 mg/dl) (%) 60.4 61.9 0.758
Charlson Comorbidity Index 1.70 	 0.05 1.77 	 0.04 0.283
Data are means 	 SEM unless indicated otherwise. *P  0.05.
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cantly lowered the proportion of patients
with SBP 140 mmHg (4.3 	 1.2%,
P  0.002), although control practices
did not (1.2 	 1.3%, NS). Intervention
practices achieved recommended SBP
values signiﬁcantly more often than con-
trol practices, attaining target SBP in an
average of 45.0% of patients compared
with 40.6% for control practices (P 
0.001).
Intervention practices demonstrated
signiﬁcant declines in mean A1C for the
cohort adjusted for age, sex, and CCI to
7.26% (P  0.02). Control practices had
no signiﬁcant change in mean A1C
(7.37%, NS). Intervention practices
achieved recommended A1C values sig-
niﬁcantly more often than control prac-
tices,attainingtargetA1Cinanaverageof
49.0% of patients compared with 43.8%
in control practices (P  0.001).
Intervention and control practices
demonstratedsigniﬁcantdecreasesinmean
LDL to 99.8 and 99.5 mg/dl, respectively.
Intervention practices achieved recom-
mended LDL values signiﬁcantly more of-
ten than control practices, attaining target
LDL in 43.0% of patients compared with
35.5% in control practices (P  0.001).
Table 4 compares the overall im-
provement between control practices and
intervention practices. Although both
groups demonstrated improvement, in-
tervention practices improved their index
of performance measures signiﬁcantly
morethancontrolpracatices(P0.001).
More importantly, evaluation of the com-
positeoutcomedemonstratedthatthenet
improvement in the average number of
recommended clinical targets (A1C, SBP,
and LDL) achieved across their entire pa-
tient population by intervention practices
from baseline to 12 months was signiﬁ-
cantly greater than that achieved by con-
trol practices from baseline to 12 months
(P0.002).Interventionpracticessignif-
icantly increased simultaneous achieve-
ment of A1C, SBP, and LDL in 12.6% of
patients compared with 8.5% in control
practices (P  0.001).
CONCLUSIONS — The TRANSLATE
trial demonstrates that 12 months after
the introduction of a multicomponent or-
ganizational intervention, primary care
practices improve signiﬁcantly more than
control practices in their ability to help
diabetic patients achieve recommended
clinical targets. This change is associated
with substantial increases in National
Committee on Quality Assurance mea-
sures. The intervention provided an elec-
tronic diabetes registry that supported
visitreminders,patient-speciﬁcphysician
alerts, proactive support of patients at
risk, and a monthly progress review. This
strategy was broadly effective across pri-
mary care practices from 17 different
health care systems and resulted in 15
Table3—Percentageofpatientsmeetingdiabetesperformancemeasuresatbaselineandafter
intervention, with change, net difference, and statistical signiﬁcance of the net difference in
performance between control and IMPACT clinics
Baseline
Intervention
period Change
Net difference
(I2  I1) 
(C2  C1) P value*
Blood pressure
monitoring
IMPACT clinics 95.1 	 0.8 96.4 	 0.6 1.3 	 0.9 3.5 	 1.7 0.050
Control clinics 94.3 	 1.1 92.2 	 1.2 2.1 	 1.4
Renal testing
IMPACT clinics 40.9 	 4.4 64.1 	 4.2 23.2 	 5.0 28.5 	 7.0 0.001
Control clinics 37.1 	 4.3 31.8 	 4.0 5.3 	 4.6
Annual eye
examination
IMPACT clinics 35.5 	 3.0 62.5 	 3.1 27.0 	 2.9 25.9 	 4.2 0.001
Control clinics 24.8 	 2.5 26.0 	 2.6 1.2 	 2.3
Foot examination
IMPACT clinics 39.4 	 4.2 68.8 	 3.8 29.4 	 5.6 35.0 	 5.6 0.001
Control clinics 39.1 	 4.2 33.5 	 3.9 5.6 	 5.4
A1C testing
IMPACT clinics 88.2 	 1.5 90.1 	 1.1 2.8 	 0.9 8.1 	 1.5 0.001
Control clinics 87.5 	 1.5 82.3 	 1.9 5.3 	 1.2
LDL cholesterol testing
IMPACT clinics 69.6 	 3.0 78.0 	 2.4 8.9 	 1.3 8.6 	 1.9 0.001
Control clinics 64.3 	 3.2 64.6 	 3.2 0.3 	 1.6
Data are means 	 SEM. *P value based on d.f.  22. C1, control practices at baseline; C2, control practices
at 12 months; I1, intervention practices at baseline; I2, intervention practices at 12 months.
Table4—Age-,sex-,andCharlsonComorbidityIndex-adjustedprocessofcareindex(Poissonmean)andcompositeoutcomemeasure(Poisson
mean) at baseline and after intervention with change, net difference, and statistical signiﬁcance of the net difference in measures between
intervention and control clinics
Baseline
Intervention
period Change
Net difference
(I2  I1) 
(C2  C1) P value*
Process of Care Index†
IMPACT clinics 3.29 	 0.114 4.58 	 0.110 1.29 	 0.042 1.07 	 0.044 0.001
Control clinics 3.48 	 0.114 3.70 	 0.113 0.22 	 0.038
Composite outcome
IMPACT clinics 1.22 	 0.054 1.39 	 0.061 0.17 	 0.030 0.15 	 0.030 0.002
Control clinics 1.16 	 0.052 1.18 	 0.053 0.02 	 0.029
Data are mean 	 SEM number of criteria measured. *P value based on d.f.  22. †Process of Care Index includes annual blood pressure monitoring, renal testing,
eye examination, foot examination, A1C testing, and LDL cholesterol testing. C1, control practices at baseline; C2, control practices at 12 months; I1, intervention
practices at baseline; I2, intervention practices at 12 months.
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viduals after 12 months. The scale of
change was large, involving 232 provid-
ersand7,101patients.Previousworkhas
demonstrated that patients who achieve
these targets simultaneously can reduce
their risk of cardiovascular events by up
to 53% (28).
Importantworkﬂowchangesinprac-
tices included 1) identiﬁcation and case
management of patients not achieving
goals, 2) provider alerts with integrated
decision support during visits, and 3)
monthlyreviewbytheLPCwithfeedback
to individual providers. The establish-
ment of an electronic registry was integral
to supporting these efforts.
Although all practices signiﬁcantly
improved process measures, only inter-
vention clinics signiﬁcantly improved
clinical outcomes. The weak association
between process and outcome measures
has implications for the selection of qual-
ity measures for diabetes care and con-
ﬁrms that process measures are more
quickly and easily improved than clinical
outcomes.
A detailed economic analysis is un-
derway; however, the total cost of the in-
tervention was small from the perspective
of the health care system. Site coordina-
tors contributed 1 h per provider FTE
per month, and LPCs were reimbursed
for1hpermonth.Two-thirdsofpractices
had software added to existing com-
puters, whereas the remaining third re-
quired one computer and a printer for
implementation.
Although a signiﬁcant difference in
clinical outcomes was seen at 12
months, the study does not suggest
how long improvement would continue
or the maximal improvement expected.
The study was not powered to evaluate
the success of introducing individual
intervention components. At the com-
pletion of the 12-month intervention
period, all control clinics chose to im-
plement the TRANSLATE intervention.
To date, all 24 clinics continue to use
the diabetes registry or have converted
to an electronic health record with sim-
ilar functionality.
Despite the use of a randomized
controlled design with rigorous atten-
tion to implementation details, a num-
ber of factors limit interpretation.
Practices were in a single geographic re-
gion and volunteered for the study. Ef-
fects may be different in other regions
with different organizational systems or
in practices unwilling or unable to
change. In addition, average A1C
among practices was very good at base-
line (7.3%) and may have limited over-
all improvement. Intervention practices
with the highest baseline A1Cs experi-
enced the largest decrease.
In summary, the introduction of a
multicomponent organizational inter-
vention in community primary care
practicessigniﬁcantlyimprovestheper-
centage of type 2 diabetic patients
achieving recommended values for a
composite of SBP, LDL, and A1C. Addi-
tional studies are needed to examine
sustainability, and it is not known
whether this methodology will have
similar beneﬁts in care of other chronic
diseases. This combination of compo-
nents provides a proven strategy for ini-
tiating improvement in clinical diabetes
care for many primary care practices.
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